AU2001288973A1 - Non-genetic based protein disease markers - Google Patents
Non-genetic based protein disease markersInfo
- Publication number
- AU2001288973A1 AU2001288973A1 AU2001288973A AU8897301A AU2001288973A1 AU 2001288973 A1 AU2001288973 A1 AU 2001288973A1 AU 2001288973 A AU2001288973 A AU 2001288973A AU 8897301 A AU8897301 A AU 8897301A AU 2001288973 A1 AU2001288973 A1 AU 2001288973A1
- Authority
- AU
- Australia
- Prior art keywords
- based protein
- disease markers
- protein disease
- genetic based
- genetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/321—Arterial hypertension
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66024200A | 2000-09-12 | 2000-09-12 | |
US09/660,242 | 2000-09-12 | ||
US09/886,271 | 2001-06-22 | ||
US09/886,271 US20020072492A1 (en) | 2000-09-12 | 2001-06-22 | Non-genetic based protein disease markers |
PCT/US2001/028268 WO2002022165A1 (en) | 2000-09-12 | 2001-09-12 | Non-genetic based protein disease markers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001288973A1 true AU2001288973A1 (en) | 2002-03-26 |
Family
ID=27098029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001288973A Abandoned AU2001288973A1 (en) | 2000-09-12 | 2001-09-12 | Non-genetic based protein disease markers |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020072492A1 (en) |
AU (1) | AU2001288973A1 (en) |
WO (1) | WO2002022165A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691645B2 (en) | 2001-01-09 | 2010-04-06 | Agilent Technologies, Inc. | Immunosubtraction method |
US20030009293A1 (en) * | 2001-01-09 | 2003-01-09 | Anderson Norman G. | Reference database |
PT1882946E (en) * | 2003-12-23 | 2010-04-21 | Roche Diagnostics Gmbh | Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6 |
US20080228698A1 (en) | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Creation of Attribute Combination Databases |
US20090043752A1 (en) | 2007-08-08 | 2009-02-12 | Expanse Networks, Inc. | Predicting Side Effect Attributes |
US8108406B2 (en) | 2008-12-30 | 2012-01-31 | Expanse Networks, Inc. | Pangenetic web user behavior prediction system |
WO2010077336A1 (en) | 2008-12-31 | 2010-07-08 | 23Andme, Inc. | Finding relatives in a database |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452886A (en) * | 1981-09-21 | 1984-06-05 | Henry Robert P | Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems |
US5225330A (en) * | 1988-08-01 | 1993-07-06 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic kit and diagnostic method utilizing carbohydrate receptors |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5629190A (en) * | 1992-08-10 | 1997-05-13 | Rhone-Poulenc Chimie | Polypeptides possessing a nitrilase activity and method of converting nitriles to carboxylates by means of said polypeptides |
JPH07270319A (en) * | 1994-03-30 | 1995-10-20 | Mochida Pharmaceut Co Ltd | Method for measuring substance containing adenyl group using heteropoly acid |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5723320A (en) * | 1995-08-29 | 1998-03-03 | Dehlinger; Peter J. | Position-addressable polynucleotide arrays |
-
2001
- 2001-06-22 US US09/886,271 patent/US20020072492A1/en not_active Abandoned
- 2001-09-12 AU AU2001288973A patent/AU2001288973A1/en not_active Abandoned
- 2001-09-12 WO PCT/US2001/028268 patent/WO2002022165A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20020072492A1 (en) | 2002-06-13 |
WO2002022165A1 (en) | 2002-03-21 |
WO2002022165A9 (en) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224480A1 (en) | Lace-less shoe | |
GB0001704D0 (en) | Protein | |
AU2001233626A1 (en) | Marker | |
AU2001234893A1 (en) | Protein mapping | |
AU2001286721A1 (en) | Human interleukin-four induced protein | |
AU2002367266A1 (en) | Disease markers for renal diseaes and utilization thereof | |
GB0011185D0 (en) | Protein | |
AU2001282149A1 (en) | Improved marker | |
AU2001295777A1 (en) | Target | |
AU2001288973A1 (en) | Non-genetic based protein disease markers | |
GB0024446D0 (en) | Protein | |
AU2002223788A1 (en) | Tannages | |
AU2001244863A1 (en) | Apoptin-associating protein | |
AU2001277236A1 (en) | Shoe construction | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2002249453A1 (en) | Enzyme and snp marker for disease | |
AU2001284590A1 (en) | Shoe | |
GB0009181D0 (en) | Protein | |
AU2001278777A1 (en) | Irap-binding protein | |
AU2001263445A1 (en) | Methods for protein design | |
AU2001241044A1 (en) | Mitf-associated proteins | |
IL150774A0 (en) | Apoptin-associating protein | |
AU2001244935A1 (en) | Animal scarer | |
AU2001294911A1 (en) | Carbohydrate-associated proteins | |
GB0119929D0 (en) | Protein |